Charles Halpern Letter to ICOC
By Charles Halpern
| 01. 03. 2005
Dear Members of the ICOC:
I reviewed the agenda for the January 6 meeting with concern and surprise. I find that the Bagley-Keene Open Meetings Act is still not being complied with and that the Committee is being invited to rush into the core of its work without having laid an appropriate foundation.
I write to encourage you to take charge of the mission of the Institute and to begin to function as a deliberative body, allowing due time for serious consideration of complex issues, with public involvement in the manner prescribed by California law.
I suggest that the ICOC take the following steps:
1. Clarify the scope of the program.
Though there is an unfortunate ambiguity in the intertwined provisions of Prop. 71, it is clear that the Institute for Regenerative Medicine is not limited to supporting embryonic stem cell research. It is authorized to support a broad range of medical research intended to cure or mitigate disease. How will the ICOC define the mandate? Will the construction grants that are likely to loom large in the first year's...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...